We are live on ! Find out more
TRIL

Trillium Therapeutics Inc.
TRIL

Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

2 hedge funds and large institutions have $18K invested in Trillium Therapeutics Inc. in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 181 → 2 (-179)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 177

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $1.38B → $18K (-$1.38B)

Holders
2
Holders Change
-179
Holders Change %
-98.9%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
177
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$107M
2
NMC
NEA Management Company
Maryland
-$101M
3
ACA
Avoro Capital Advisors
New York
-$100M
4
EAM
Eventide Asset Management
Massachusetts
-$91.8M
5
MF
Magnetar Financial
Illinois
-$57.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Optiver Holding
1
Optiver Holding
Netherlands
$18K – – –
BlackRock
2
BlackRock
New York
– -$107M -6,112,610 Closed
NMC
3
NEA Management Company
Maryland
– -$101M -5,736,363 Closed
ACA
4
Avoro Capital Advisors
New York
– -$100M -5,700,000 Closed
EAM
5
Eventide Asset Management
Massachusetts
– -$91.8M -5,227,376 Closed
MF
6
Magnetar Financial
Illinois
– -$57.4M -3,271,390 Closed
PCM
7
Pentwater Capital Management
Florida
– -$55.1M -3,140,000 Closed
FM
8
Frazier Management
Washington
– -$55M -3,123,107 Closed
UOC
9
UBS O'Connor
Illinois
– -$40.4M -2,300,000 Closed
VI
10
Versor Investments
New York
– -$33.8M -1,923,455 Closed
GF
11
Gabelli Funds
New York
– -$31.5M -1,793,880 Closed
WCMNY
12
Westchester Capital Management (New York)
New York
– -$28M -1,597,153 Closed
JP Morgan Chase
13
JP Morgan Chase
New York
– -$26.5M -1,510,226 Closed
FCM
14
Farallon Capital Management
California
– -$25.2M -1,435,000 Closed
State Street
15
State Street
Massachusetts
– -$25M -1,421,166 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$24.5M -1,396,216 Closed
AA
17
AQR Arbitrage
Connecticut
– -$24.5M -1,393,859 Closed
SCC
18
Spring Creek Capital
Kansas
– -$23.4M -1,330,000 Closed
Goldman Sachs
19
Goldman Sachs
New York
– -$22.2M -1,263,721 Closed
AllianceBernstein
20
AllianceBernstein
Tennessee
– -$21.2M -1,209,595 Closed
CS
21
Candriam SCA
Luxembourg
– -$20.2M -1,150,280 Closed
AAM
22
Alpine Associates Management
Florida
– -$20M -1,140,000 Closed
SCM
23
Segantii Capital Management
Hong Kong
– -$19.9M -1,135,000 Closed
CC
24
Carlson Capital
Texas
– -$15.8M -900,000 Closed
FFM
25
Fairmount Funds Management
Pennsylvania
– -$15.6M -886,281 Closed
1
2 3 4 5

TRIL Hedge Fund Activity: Q4 2021 in Review

2 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Trillium Therapeutics Inc. (TRIL) for Q4 2021, worth a combined $18K — down 100% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 177 funds closed out of TRIL and 1 opened new positions — a net loss of 176 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $107M sold.

  • 2 institutional investors held Trillium Therapeutics Inc. (TRIL) as of Q4 2021, down from 181 in Q3 2021.
  • Funds reported $18K of Trillium Therapeutics Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Trillium Therapeutics Inc. positions in Q4 2021 and 177 closed out, a net change of -176 holders.
  • The largest Trillium Therapeutics Inc. seller in Q4 2021 was BlackRock, an estimated $107M sold.

Based on aggregated 13F filings for Q4 2021.